These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9871870)

  • 1. Situation with glaucoma and the state of mind in the glaucoma community.
    Kotik J
    J Glaucoma; 1998 Dec; 7(6):446-7. PubMed ID: 9871870
    [No Abstract]   [Full Text] [Related]  

  • 2. Bolstering Sisyphus.
    Van Buskirk EM
    J Glaucoma; 1998 Apr; 7(2):73-4. PubMed ID: 9559490
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical outcomes of glaucoma treatment over a patient lifetime: a Markov model (letter).
    Kymes S
    J Glaucoma; 2006 Oct; 15(5):471-2; author reply 472-3. PubMed ID: 16988613
    [No Abstract]   [Full Text] [Related]  

  • 4. Ghost cell glaucoma.
    Montenegro MH; Simmons RJ
    Int Ophthalmol Clin; 1995; 35(1):111-5. PubMed ID: 7751123
    [No Abstract]   [Full Text] [Related]  

  • 5. Progressive normal-tension Glaucoma.
    Girkin CA; Chauhan BC; Medeiros FA
    J Glaucoma; 2008; 17(7):591-3. PubMed ID: 18854739
    [No Abstract]   [Full Text] [Related]  

  • 6. [Open-angle glaucoma and hypertension of the eye. Problems of early and differential diagnosis and of therapy].
    Kashintseva LT
    Oftalmol Zh; 1988; (1):51-5. PubMed ID: 3387006
    [No Abstract]   [Full Text] [Related]  

  • 7. [Steroid induced ocular hypertension and glaucoma].
    Călugăru D; Călugăru M
    Oftalmologia; 2009; 53(3):15-33. PubMed ID: 19899544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness.
    Tuulonen A; Azuara-Blanco A
    Ophthalmology; 2009 Jan; 116(1):166-7; author reply 167. PubMed ID: 19118707
    [No Abstract]   [Full Text] [Related]  

  • 9. Cost-effectiveness.
    Brown GC; Brown MM
    Ophthalmology; 2008 Aug; 115(8):1433; author reply 1433-4. PubMed ID: 18675701
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ocular hypertension and glaucoma: the contribution of large studies to daily practice].
    Bron A
    J Fr Ophtalmol; 2002 Jun; 25(6):641-54. PubMed ID: 12223955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness.
    Lichter PR
    Ophthalmology; 2008 Oct; 115(10):1852-3; author reply 1853. PubMed ID: 18929170
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and safety of bimatoprost for the treatment of open-angle glaucoma and ocular hypertension: a three-month, open-label study in community-based practices in Thailand.
    Wanichwecha-Rungruang B; Iemsomboon W
    J Med Assoc Thai; 2005 Sep; 88(9):1228-35. PubMed ID: 16536109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glaucoma care cost-effectiveness.
    Hoskins HD
    Ophthalmology; 2009 May; 116(5):1016. PubMed ID: 19410965
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of prostaglandin analogues on the blood aqueous barrier and corneal thickness of phakic patients with primary open-angle glaucoma and ocular hypertension.
    Arcieri ES; Pierre Filho PT; Wakamatsu TH; Costa VP
    Eye (Lond); 2008 Feb; 22(2):179-83. PubMed ID: 16936646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mean standard deviations for common glaucoma treatments.
    Stewart WC; Stewart JA; Nelson LA; Kruft B
    Acta Ophthalmol; 2009 Feb; 87(1):112-4. PubMed ID: 18494738
    [No Abstract]   [Full Text] [Related]  

  • 16. When to treat ocular hypertension.
    Shuster J; Kass MA
    Ann Ophthalmol; 1983 Apr; 15(4):301-2. PubMed ID: 6660700
    [No Abstract]   [Full Text] [Related]  

  • 17. Uniocular drug trials.
    Rotchford AP; King AJ
    Ophthalmology; 2004 Dec; 111(12):2315; author reply 2315-6. PubMed ID: 15582097
    [No Abstract]   [Full Text] [Related]  

  • 18. The European Glaucoma Prevention Study and the Ocular Hypertension Treatment Study: why do two studies have different results?
    Parrish RK
    Curr Opin Ophthalmol; 2006 Apr; 17(2):138-41. PubMed ID: 16552248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uniocular drug trial.
    Jones R; Triana MI; Zaslow K; Sponsel WE
    Ophthalmology; 2005 Jun; 112(6):1170; author reply 1170-1. PubMed ID: 15936449
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of patients with ocular hypertension: a cost-effectiveness approach from the Ocular Hypertension Treatment Study.
    Rosenbaum LJ
    Am J Ophthalmol; 2007 Jan; 143(1):191-2; author reply 192-3. PubMed ID: 17188074
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.